Drug discontinuation: Decitabine Injection
FDA lists 2 presentations as To Be Discontinued. Companies: Ingenus Pharmaceuticals LLC.
- Published by source
- 2026-02-20
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Ingenus Pharmaceuticals LLC
- Products
- Decitabine Injection
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: To Be Discontinued
Remedy / actions:
- Labeler: BluePoint Laboratories; Discontinuation of the manufacture of the drug
- Discontinuation of the manufacture of the drug
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2026-02-20
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #963 | new | 2026-10-22 | 7c246c90387c…287f26 | 854dd2d693fc…b79bf8 |
Chain head: #1076 8ad5adc30b9b…88ce20